Noninvasive Transcutaneous Vagus Nerve Stimulation Decreases Whole Blood Culture-Derived Cytokines and Chemokines: A Randomized, Blinded, Healthy Control Pilot Trial
Neuromodulation Technology at the Neural Interface2016Vol. 19(3), pp. 283–291
Citations Over TimeTop 10% of 2016 papers
Imanuel Lerman, Richard L. Hauger, Linda S. Sorkin, J. Proudfoot, Bryan A. Davis, Andy Huang, Katie Jing Kay Lam, Bruce J. Simon, Dewleen G. Baker
Related Papers
- → Vagus nerve stimulation for epilepsy: A review of central mechanisms(2012)181 cited
- → First‐in‐human microelectrode recordings from the vagus nerve during clinical vagus nerve stimulation(2024)7 cited
- → Vagus nerve stimulation in clinical practice(2016)35 cited
- → Vagus nerve stimulation in pediatric patients with failed epilepsy surgery(2020)15 cited
- → O038 / #883 LARYNGEAL MOTOR EVOKED POTENTIALS: CLINICAL BENEFIT IN VAGUS NERVE STIMULATION USING A SYNCHRONIZED PROGRAMMABLE IMPLANT(2022)